The association between charlson comorbidity index and the medical care cost of cancer: A retrospective study

Seok-Jun Yoon, Eun Jung Kim, Hyun Ju Seo, In Hwan Oh

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background. This study compared comorbidity-related medical care cost associated with different types of cancer, by examining breast (N=287), colon (N=272), stomach (N=614), and lung (N=391) cancer patients undergoing surgery. Methods. Using medical benefits claims data, we calculated Charlson Comorbidity Index (CCI) and total medical cost. The effect of comorbidity on the medical care cost was investigated using multiple regression and logistic regression models and controlling for demographic characteristics and cancer stage. Results. The treatment costs incurred by stomach and colon cancer patients were 1.05- and 1.01-fold higher, respectively, in patients with higher CCI determined. For breast cancer, the highest costs were seen in those with chronic obstructive pulmonary disease (COPD), but the increase in cost reduced as CCI increased. Colon cancer patients with diabetes mellitus and a CCI = 1 score had the highest medical costs. The lowest medical costs were incurred by lung cancer patients with COPD and a CCI = 2 score. Conclusion. The comorbidities had a major impact on the use of medical resources, with chronic comorbidities incurring the highest medical costs. The results indicate that comorbidities affect cancer outcomes and that they must be considered strategies mitigating cancer's economic and social impact.

Original languageEnglish
Article number259341
JournalBioMed Research International
Volume2015
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Health care
Health Care Costs
Comorbidity
Retrospective Studies
Costs
Neoplasms
Costs and Cost Analysis
Pulmonary diseases
Colonic Neoplasms
Chronic Obstructive Pulmonary Disease
Logistic Models
Breast Neoplasms
Medical problems
Surgery
Social Change
Logistics
Stomach Neoplasms
Lung Neoplasms
Stomach
Diabetes Mellitus

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

The association between charlson comorbidity index and the medical care cost of cancer : A retrospective study. / Yoon, Seok-Jun; Kim, Eun Jung; Seo, Hyun Ju; Oh, In Hwan.

In: BioMed Research International, Vol. 2015, 259341, 01.01.2015.

Research output: Contribution to journalArticle

@article{ec93dc24e07345a7b44efb8d6544b7b4,
title = "The association between charlson comorbidity index and the medical care cost of cancer: A retrospective study",
abstract = "Background. This study compared comorbidity-related medical care cost associated with different types of cancer, by examining breast (N=287), colon (N=272), stomach (N=614), and lung (N=391) cancer patients undergoing surgery. Methods. Using medical benefits claims data, we calculated Charlson Comorbidity Index (CCI) and total medical cost. The effect of comorbidity on the medical care cost was investigated using multiple regression and logistic regression models and controlling for demographic characteristics and cancer stage. Results. The treatment costs incurred by stomach and colon cancer patients were 1.05- and 1.01-fold higher, respectively, in patients with higher CCI determined. For breast cancer, the highest costs were seen in those with chronic obstructive pulmonary disease (COPD), but the increase in cost reduced as CCI increased. Colon cancer patients with diabetes mellitus and a CCI = 1 score had the highest medical costs. The lowest medical costs were incurred by lung cancer patients with COPD and a CCI = 2 score. Conclusion. The comorbidities had a major impact on the use of medical resources, with chronic comorbidities incurring the highest medical costs. The results indicate that comorbidities affect cancer outcomes and that they must be considered strategies mitigating cancer's economic and social impact.",
author = "Seok-Jun Yoon and Kim, {Eun Jung} and Seo, {Hyun Ju} and Oh, {In Hwan}",
year = "2015",
month = "1",
day = "1",
doi = "10.1155/2015/259341",
language = "English",
volume = "2015",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - The association between charlson comorbidity index and the medical care cost of cancer

T2 - A retrospective study

AU - Yoon, Seok-Jun

AU - Kim, Eun Jung

AU - Seo, Hyun Ju

AU - Oh, In Hwan

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background. This study compared comorbidity-related medical care cost associated with different types of cancer, by examining breast (N=287), colon (N=272), stomach (N=614), and lung (N=391) cancer patients undergoing surgery. Methods. Using medical benefits claims data, we calculated Charlson Comorbidity Index (CCI) and total medical cost. The effect of comorbidity on the medical care cost was investigated using multiple regression and logistic regression models and controlling for demographic characteristics and cancer stage. Results. The treatment costs incurred by stomach and colon cancer patients were 1.05- and 1.01-fold higher, respectively, in patients with higher CCI determined. For breast cancer, the highest costs were seen in those with chronic obstructive pulmonary disease (COPD), but the increase in cost reduced as CCI increased. Colon cancer patients with diabetes mellitus and a CCI = 1 score had the highest medical costs. The lowest medical costs were incurred by lung cancer patients with COPD and a CCI = 2 score. Conclusion. The comorbidities had a major impact on the use of medical resources, with chronic comorbidities incurring the highest medical costs. The results indicate that comorbidities affect cancer outcomes and that they must be considered strategies mitigating cancer's economic and social impact.

AB - Background. This study compared comorbidity-related medical care cost associated with different types of cancer, by examining breast (N=287), colon (N=272), stomach (N=614), and lung (N=391) cancer patients undergoing surgery. Methods. Using medical benefits claims data, we calculated Charlson Comorbidity Index (CCI) and total medical cost. The effect of comorbidity on the medical care cost was investigated using multiple regression and logistic regression models and controlling for demographic characteristics and cancer stage. Results. The treatment costs incurred by stomach and colon cancer patients were 1.05- and 1.01-fold higher, respectively, in patients with higher CCI determined. For breast cancer, the highest costs were seen in those with chronic obstructive pulmonary disease (COPD), but the increase in cost reduced as CCI increased. Colon cancer patients with diabetes mellitus and a CCI = 1 score had the highest medical costs. The lowest medical costs were incurred by lung cancer patients with COPD and a CCI = 2 score. Conclusion. The comorbidities had a major impact on the use of medical resources, with chronic comorbidities incurring the highest medical costs. The results indicate that comorbidities affect cancer outcomes and that they must be considered strategies mitigating cancer's economic and social impact.

UR - http://www.scopus.com/inward/record.url?scp=84939504285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939504285&partnerID=8YFLogxK

U2 - 10.1155/2015/259341

DO - 10.1155/2015/259341

M3 - Article

C2 - 26347086

AN - SCOPUS:84939504285

VL - 2015

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 259341

ER -